Health Dictionary Find a Doctor

Henoch-Schönlein purpura

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

For patient information click here

Synonyms and keywords: Anaphylactoid purpura; purpura rheumatica; Schönlein–Henoch purpura

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In medicine (rheumatology and pediatrics) Henoch-Schönlein purpura (HSP, also known as allergic purpura) is a systemic vasculitis (inflammation of blood vessels) characterized by deposition of immune complexes containing the antibody IgA, especially in the skin and kidney. It occurs mainly in children. Typical symptoms include palpable purpura (small hemorrhages in the skin), joint pains and abdominal pain. Most cases are self-limiting and require no treatment apart from symptom control, but the disease may relapse (in 33% of cases) and cause irreversible kidney damage (in 1%).[1]

Historical Perspective

The disease was named Henoch-Schonlein purpura (HSP) after Johann Schonlein and Eduard Henoch due to their role in establishing the clinical manifestations of the disease

Classification

Pathophysiology

Henoch-Schönlein purpura (HSP) is an immune complex-mediated disease with circulating immune complexes and IgA rheumatoid factors usually follows upper respiratory tract infections, various viruses, and the bacteria have been implicated as triggers of the disease.

Causes

The common causes of Henoch-Schönlein purpura (HSP) are infections, medications, hypersesitivity, vaccinations, genetics etc.

Differentiating Henoch-Schönlein Purpura from other Diseases

Henoch-Schönlein purpura should be differentiated from other immune complex mediated small vessel vasculitis such as Anti-glomerular basement membrane disease, Cryoglobulinemic vasculitis, Hepatitis C virus-associated cryoglobulinemic vasculitis, Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis).

Epidemiology and Demographics

The incidence of HSP is approximately 6-20 cases per 100,000 individuals. The prevalence of HSP is more in children of 4-6 years age group. HSP usually affects Caucasians than any other ethnic groups. Males are more commonly affected by HSP than females. The Male to female ratio is approximately 1.5-2:1.

Risk Factors

Henoch-Schönlein purpura (HSP) is associated with following risk factors it’s most common in children of 2 to 6 years, involves young boys more than girls, Asian and white race, spring, fall and winter months, Group A streptococci, Mycoplasma, Epstein-Barr virus infections, and environmental exposure of allergens, organophosphates, cold temperature.

Screening

There is insufficient evidence to recommend routine screening for HSP.

Natural History, Complications and Prognosis

Henoch-Schönlein purpura is a self-limiting illness in the majority of patients but can rarely lead to complications such as proteinuria, End Stage Renal Disease, myocardial infarction, pulmonary hemorrhage, pleural effusion, intussusception, orchitis, GI bleeding, bowel infarction, seizures, neuropathies. The prognosis is usually good but rarely its worse in adults with renal involvement.

Diagnosis

Henoch-Schönlein purpura is diagnosed using a biopsy of the skin and kidney.

History and Symptoms

The signs and symptoms of Henoch-Schönlein purpura (HSP) are skin lesions such as palpable purpura, abdominal pain, melena, bloody diarrhea, hematemesis, duodenal ulcers, arthralgia.

Physical Examination

Physical examination of patients with HSP is usually remarkable for palpable purpura.

Laboratory Findings

There is no specific diagnostic test available for HSP. Platelet count, coagulation studies such as PT, aPTT, and BT are done to rule out other diseases like coagulopathies. They are usually normal. Urinalysis is done to check for any blood in the urine or proteinuria for renal involvement. Serum IgA levels are elevated in the majority of patients with HSP, and in patients with renal involvement higher IgA levels are detected.

Electrocardiogram

There are no ECG findings associated with Henoch-Schönlein purpura.

Chest X Ray

There are no x-ray findings associated with Henoch-Schönlein purpura (HSP).

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Surgery

Surgical intervention is not recommended for the management of Henoch-Schönlein purpura.

Medical Therapy

Henoch-Schönlein Purpura (HSP) is usually treated with supportive management by adequate hydration, balancing fluid and electrolyte, and controlling hypertension. Symptoms such as arthritis, edema, fever are treated with acetaminophen, leg elevation, and adequate hydration. Pharmacological management includes use of analgesics, NSAIDs, corticosteriods and various other immuno-suppressants. Plasmapheresis may be effective in delaying the progression of kidney disease and is usually done in addition to steroids.

Primary Prevention

There are no established measures for the primary prevention of Henoch-Schönlein purpura.

Secondary Prevention

There are no established measures for the secondary prevention of Henoch-Schönlein purpura.

Cost-Effectiveness of Therapy

Future or Investigational Therapies

References

  1. ↑ Saulsbury FT (2001). “Henoch-Schönlein purpura”. Curr Opin Rheumatol. 13 (1): 35–40. PMID 11148713.

Template:WH Template:WS

Historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The disease was named Henoch-Schonlein purpura (HSP) after Johann Schonlein and Eduard Henoch due to their role in establishing the clinical manifestations of the disease.

Historical perspective

  • The historical perspective of Henoch-Schönlein purpura:[1]
  • The first case of Henoch-Schönlein purpura was described by Herberden in the year 1801.
  • He described a young boy with a skin rash, abdominal pain, hematuria, and subcutaneous edema.
  • The disease was named Henoch-Schonlein purpura (HSP) after Johann Schonlein and Eduard Henoch due to their role in establishing the clinical manifestations of the disease.
  • Johann Schonlein identified purpura and joint pain as symptoms of HSP, which at the time he referred to as purpura rheumatica.
  • Eduard Henoch described the associated gastrointestinal and renal complications of the HSP.

References

  1. ↑ Kennedy DW (January 1979). “Timely tips about Medicare”. Geriatrics. 34 (1): 76–9. PMID 365692.

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There is no established system for the classification of Henoch-Schönlein purpura.

Classification

There is no established system for the classification of Henoch-Schönlein purpura.

References

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Henoch-Schönlein purpura (HSP) is an immune complex-mediated disease with circulating immune complexes and IgA rheumatoid factors usually follows upper respiratory tract infections, various viruses, and the bacteria have been implicated as triggers of the disease.

Pathophysiology

The pathophysiology of HSP:[1][2][3]

Pathology

Biopsy: [4][5][6]

Skin biopsy

Renal biopsy

References

  1. ↑ Yang YH, Yu HH, Chiang BL (2014). “The diagnosis and classification of Henoch-Schönlein purpura: an updated review”. Autoimmun Rev. 13 (4–5): 355–8. doi:10.1016/j.autrev.2014.01.031. PMID 24424188.
  2. ↑ Trnka P (December 2013). “Henoch-Schönlein purpura in children”. J Paediatr Child Health. 49 (12): 995–1003. doi:10.1111/jpc.12403. PMID 24134307.
  3. ↑ Rigante D, Castellazzi L, Bosco A, Esposito S (August 2013). “Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura?”. Autoimmun Rev. 12 (10): 1016–21. doi:10.1016/j.autrev.2013.04.003. PMID 23684700.
  4. ↑ Jennette JC, Falk RJ (November 1997). “Small-vessel vasculitis”. N. Engl. J. Med. 337 (21): 1512–23. doi:10.1056/NEJM199711203372106. PMID 9366584.
  5. ↑ Chen JY, Mao JH (February 2015). “Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management”. World J Pediatr. 11 (1): 29–34. doi:10.1007/s12519-014-0534-5. PMID 25557596.
  6. ↑ Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, Hosoya M (2013). “Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment”. Fukushima J Med Sci. 59 (1): 15–26. PMID 23842510.

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The common causes of Henoch-Schönlein purpura (HSP) are infections, medications, hypersensitivity, vaccinations, genetics etc.

Causes

  • The causes of the HSP is as follows:[1][2][3][4][5][6]
  • The exact cause of HSP is not clear.

References

  1. ↑ Davin JC, Coppo R (October 2014). “Henoch-Schönlein purpura nephritis in children”. Nat Rev Nephrol. 10 (10): 563–73. doi:10.1038/nrneph.2014.126. PMID 25072122.
  2. ↑ Micheletti RG, Werth VP (2015). “Small vessel vasculitis of the skin”. Rheum. Dis. Clin. North Am. 41 (1): 21–32, vii. doi:10.1016/j.rdc.2014.09.006. PMID 25399937.
  3. ↑ Zhdanova LV, Patrushev LI, Dolgikh VV, Bimbaev AB, KhoÄ­kova O (2014). “[The contribution of genes polymorphism of thrombophilia in clinical variability of hemorrhagic vasculitis]”. Vestn. Akad. Med. Nauk SSSR (in Russian) (3–4): 61–4. PMID 25306598. Vancouver style error: initials (help)
  4. ↑ Rigante D, Castellazzi L, Bosco A, Esposito S (August 2013). “Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura?”. Autoimmun Rev. 12 (10): 1016–21. doi:10.1016/j.autrev.2013.04.003. PMID 23684700.
  5. ↑ Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B (July 2015). “IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects”. Autoimmun Rev. 14 (7): 579–85. doi:10.1016/j.autrev.2015.02.003. PMID 25688001.
  6. ↑ Pillebout E, Niaudet P (March 2008). “[Henoch-Schönlein purpura]”. Rev Prat (in French). 58 (5): 507–11. PMID 18524107.


Template:WH Template:WS

Differentiating Henoch-Schönlein purpura from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Henoch-Schönlein purpura should be differentiated from other immune complex mediated small vessel vasculitis such as Anti-glomerular basement membrane disease, Cryoglobulinemic vasculitis, Hepatitis C virus-associated cryoglobulinemic vasculitis, Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis).

Differentiating Henoch-Schönlein Purpura from other Diseases

Henoch-Schönlein purpura should be differentiated from other immune complex mediated small vessel vasculitis such as Anti-glomerular basement membrane disease, Cryoglobulinemic vasculitis, Hepatitis C virus-associated cryoglobulinemic vasculitis, Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis).

Differential Diagnosis

Abbreviations: ABG= Arterial blood gas, ANA= Antinuclear antibody, ANP= Atrial natriuretic peptide, ASO= Antistreptolysin O antibody, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure, PCR= Polymerase chain reaction, PFT= Pulmonary function test.

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Headache Fever Weight loss Arthralgia Claudication Bruit HTN Focal neurological disorder Biomarker CBC ESR Other CT scan Angiography Ultrasound/ Echocardiography Other
Large-Vessel Vasculitis Takayasu arteritis[1] + +/- + + + +/- +/- MMP-3 and MMP-9 Leukocytosis, Anemia ↑ ↑CRP Aneurysmal dilatation of the aorta Blood vessel stenosis Circumferential thickening of the arterial wall (Macaroni sign) PET-scan, Cardiac CT Granulomatous inflammation of arteries Arteriography Coronary aneurysm
Giant cell arteritis[2] + + +/- +/- Pentraxin 3 (PTX3) Normal ↑ ↑CRP Stenosis, Occlusion, Dilatation Aneurysm Mural inflammation in MRA Granulomatous inflammation of arteries Biopsy  Jaw pain and claudication
Neurological disease Cerebral aneurysm[3] + +/- + Normal Normal Well-defined round, slightly hyperattenuating lesion Bulging out of the main lumen Heterogeneous signal intensity in MRA Layers of smooth muscle cells, Intact endothelium Digital subtraction angiography (DSA) Nausea, Vomiting
Neurofibromatosis type 1[4] +/- +/- + + NF1 mutated gene Normal Normal Neurofibromin gene Bone abnormalities  Optical coherence tomography angiography (OCTA) Optic nerve gliomas in MRI Elongated spindle-shaped cells in neurofibromas NIH diagnostic criteria Cafe au Lait spot
Neurofibromatosis type 2[5] +/- +/- +/- + NF2 mutated gene Normal Normal Schwannomin Meningioma, Schwannoma, Ependymoma Fluorescein angiography showed retinal hamartoma Localized schwannomas in nerve ultrasound Schwannoma in MRI Encapsulated biphasic nerve sheath tumor NIH diagnostic criteria Hearing loss, Vision loss
Systemic disease Fibromuscular dysplasia[6] + +/- + + + + +/- Transforming growth factor ÎČ (TGF-ÎČ) Normal ↑ ↑ Cr or BUN Alternating stenosis and dilatations in CT angiography Stenosis in the renal arteries Luminal narrowing alternating with dilatation (Beads sign) Focal concentric, long-segment tubular stenosis or outpouching in MRA Fibrodysplastic changes, Collagen deposition Digital subtraction angiography (DSA)  Spontaneous coronary artery dissection (SCAD)
Ehlers-Danlos syndrome[7] + +/- +/- +/- TGF-ÎČ Normal Normal Cultured skin fibroblasts Multiple vascular segments with aneurysms and dissections Dissection of the posterolateral branch of the left circumflex coronary artery (LCx) Visceral arteries abnormality Vascular abnormalities in MRA Thin and rare collagen bundles in the dermis History and physical examination Bleeding, Bruisability, Heart murmur
Polymyalgia rheumatica (PMR)[8] + +/- + Plasma fibrinogen Normocytic, normochromic anemia ↑ CRP Periodontoid localization of calcification Vessel wall thickening, Increased mural contrast enhancement Subacromial or subdeltoid bursitis High F-FDG accumulation around the joints in FDG PET-CT Small angular fibers, Pyknotic nuclear clumps, or target-targetoid fibers Joint stiffness, Fatigue
Amyloidosis[9] +/- +/- +/- + + Immunoglobulin light chain(Amyloid) Anemia Normal ↑ Cr or BUN,

↑ ALT or AST

Diffusely hypoattenuating and enlarged liver Amyloid deposition in the media and adventitia of small arteries  Solid organs increased echogenicity Tc-DPD for cardiac amyloid deposits Extracellular deposition of fibrillar proteins Biopsy Cardiomegaly, Dyspnea
Diseases Headache Fever Weight loss Arthralgia Claudication Bruit HTN Focal neurological disorder Biomarker CBC ESR Other CT scan Angiography Ultrasound/ Echocardiography Other Histopathology Gold standard Additional findings
Medium-Vessel Vasculitis Polyarteritis nodosa[10] + + + + + + +/- +/- LAMP-2 protein autoantibodies Leukocytosis, Normochromic anemia, Thrombocytosis ↑ ↑ Cr or BUN,

↑ ALT or AST, Proteinuria

Focal regions of infarction or hemorrhage Multiple microaneurysms, Hemorrhage due to focal rupture, Occlusion Aneurysms and renal arteriovenous fistula in color Doppler sonography Necrotizing inflammatory lesions Angiography Sudden weight loss, Abdominal pain
Hepatitis B virus-associated polyarteritis nodosa[11] +/- +/- + + +/- +/- + HBsAg Leukocytosis, Normochromic anemia, Thrombocytosis ↑ ↑ ALT or AST Focal regions of infarction or hemorrhage Microaneurysms in mesenteric artery Aneurysms and renal arteriovenous fistula in color Doppler sonography Necrotizing inflammatory lesions Angiography Peripheral neuropathy, Livedo reticularis
Kawasaki disease[12] + +/- + + +/- NT-proBNP, Meprin A, Filamin C Normochromic anemia, ↑WBC with a left shift, Thrombocytosis  ↑ Acute-phase reactants, ↓Cholesterol, ↓HDL, ↓ApolipoA Coronary artery calcifications Coronary artery aneurysms, stenosis or occlusion Coronary artery anomaly in echocardiography Electron beam CT (EBCT) Acute destruction of the media by neutrophils, with loss of elastic fibers History and physical examination Diarrhea, Vomiting
Infectious disease Parvovirus B19 infection[13] + + + + +/- B19 DNA, ↓Reticulocyte count Anemia ↑ anti–parvovirus B19 IgM Hydrops in fetal ultrasonography B19 DNA Purpuric rash, Erythema multiforme
Scarlet fever[14] + + +/- + Antistreptolysin-O (ASO) titers Leukocytosis ↑ ↑CRP Thickened pulmonary markings if pneumonia Sparse neutrophilic perivascular infiltrate History and physical examination Sand-paper rashes, Sore throat
Toxic shock syndrome[15] + + + + +/- Procalcitonin Leukocytosis with left shift ↑ Myoglobinuria, Sterile pyuria Acute respiratory distress syndrome Necrolysis of keratinocytes in epidermis, Perivascular lymphocytic infiltrate Clinical criteria Peeling or rashes, Organ dysfunction
Mononucleosis[16] + + + + EBV DNA Atypical lymphocyte ↑ Heterophile antibodies CNS involvement Splenomegaly Encephalitis in MRI Lymphoproliferative response in oropharynx, Lymphocytic infiltration in spleen Heterophile antibody test Splenomegaly, Palatal petechiae
Leptospirosis[17] + + + + +/- IL-6, IL-8 and IL-10 Anemia ↑Cr or BUN,

↑ALT or AST, Proteinuria

 Diffuse alveolar hemorrhage Toxin-mediated break down of endothelial cell membranes of capillaries Culture and the microscopic agglutination test Red eyes, Skin rash
Lyme Disease[18] +/- + +/- + +/- CXCL9 (MIG), CXCL10 (IP-10) and CCL19 (MIP3B) Leukopenia, Thrombocytopenia Microscopic hematuria, Proteinuria, ↑ALT or AST Punctate lesions in periventricular white matter in brain SPECT Acrodermatitis chronica atrophicans Serologic tests Erythema migrans
Measles[19] +/- + +/- + Measles IgM Leukopenia, Lymphocytosis, Thrombocytopenia ↑ALT or AST Pneumonia CXR Spongiosis and vesiculation in the epidermis with scattered dyskeratotic keratinocytes PCR Generalized rash, Cough, Coryza, or Conjunctivitis
Rocky Mountain Spotted Fever[20] + + + + R rickettsii serology Thrombocytopenia, Anemia  ↑ALT or AST, Hyponatremia Infarction, edema, and meningeal enhancement Myocardial or conduction abnormalities in echocardiography Immunofluorescent or immunoperoxidase staining of R rickettsii Clinical criteria and tick exposure Rash on the palms and soles
Staphylococcal Scalded Skin Syndrome[21] + + + + +/- +/- Anti exfoliatin and anti alpha-toxin antibodies Leukocytosis with left shift ↑ Blood culture Pneumonia Intraepidermal blister, dense superficial perivascular lymphohistiocytic infiltrate  Blood culture and clinical findings Widespread skin erythema, fluid-filled blisters
Toxic Epidermal Necrolysis[22] + + +/- MicroRNA-124 Normochromic normocytic anemia, Eosinophilia ↑ Fluid loss and electrolyte abnormalities Tracheobronchial inflammation Necrotic keratinocytes with full-thickness epithelial necrosis Histopathology and clinical findings Erythematous macular rash with purpuric centers
Cardiovascular disease Atrial Myxoma[23] +/- +/- Calretinin Mild anemia, Leukocytosis ↑ ↑IL-6 Atrial filling defect larger than a thrombus Tumor location, size, attachment, and mobility in echocardiography Size, shape, and surface characteristics in MRI Lipidic cells embedded in a vascular myxoid stroma Echocardiography Dyspnea on exertion, Syncope
Cholesterol Embolism[24] +/- +/- + + IL-5 Eosinophilia, Leukocytosis   ↑ Eosinophiluria Thoracic and abdominal aortic sources of embolism Atheroembolism in abdominal aorta and the lower extremity arteries Excluding an intracardiac source of embolism with echocardiography  Birefringent crystals or biconvex needle-shaped ghostly clefts within the arterial lumen Angiography  Livedo reticularis,

Ischemic patches

Segmental arterial mediolysis[25] + + + + +/- Leukocytosis Visceral artery aneurysm in CT angiography Alternating aneurysms and stenoses (beading) Retroperitoneal hematoma Disruption of the smooth muscle in the media Angiography  Hematuria, Ischemic colitis
Systemic disease Antiphospholipid Syndrome[26] + + +/- Antiphospholipid antibodies Thrombocytopenia, Hemolytic anemia Lupus anticoagulant (LA) Stroke,

Pulmonary embolism, Budd-Chiari syndrome

Thrombus in major vessels Valve thickening, vegetations, or insufficiency in echocardiography Noninflammatory bland thrombosis without perivascular inflammation Hx of thrombosis and antiphospholipid antibodies Miscarriage, Pulmonary hypertension
Juvenile Idiopathic Arthritis[27] + +/- Rheumatoid factor (RF), S100A12 Lymphocytosis, Thrombocytopenia ↑ Myeloid-related proteins 8/14 (MRP8/14) Synovial hypertrophy, Joint effusions Cerebral vasculitis Inflamed synovium Bone scanning Vascular congestion, RBC extravasation, Venular lumen occlusion Conventional radiography Evanescent rash, Dactylitis 
Diseases Headache Fever Weight loss Arthralgia Claudication Bruit HTN Focal neurological disorder Biomarker CBC ESR Other CT scan Angiography Ultrasound/ Echocardiography Other Histopathology Gold standard Additional findings
Small-Vessel Vasculitis ANCA-associated vasculitis Microscopic polyangiitis[28] + +/- + Anti-PR3 antibody (C-ANCA) (40%), Anti-MPO antibody (P-ANCA) (60%) Leukocytosis, Normocytic anemia ↑ Proteinuria, Erythrocyte casts Suspected pancreatitis Mesenteric angiography for differentiating from polyarteritis nodosa Bilateral nodular, and patchy opacities in CXR Glomerulonephritis with focal necrosis, crescent formation, and lack or paucity of immunoglobulin deposits Histological confirmation Rash, Hemoptysis 
Granulomatosis with polyangiitis (Wegener’s)[29] + +/- +/- + Anti-PR3 antibody (C-ANCA) (90%), Anti-MPO antibody (P-ANCA) (10%) Leukocytosis, Normochromic normocytic anemia ↑ ↑Cr or BUN, Hypoalbuminemia Consolidation, Patchy or diffuse ground-glass opacities Occlusion or stenosis of LAD and RCA in coronary angiography Single or multiple nodules and masses with cavitation in CXR Parenchymal necrosis, Granulomatous inflammation Histological confirmation Conjunctivitis,

Episcleritis,

Uveitis,

Optic nerve vasculitis

Eosinophilic granulomatosis with polyangiitis

(Churg-Strauss)[30]

+/- + + Anti-MPO antibody (P-ANCA) (40%), Eotaxin-3 Eosinophilia, Anemia ↑ ↑Cr or BUN, Proteinuria, Erythrocyte casts, ↑IgE levels Significant enlargement of peripheral pulmonary arteries Myocardial ischemia and infarction in coronary angiography Congestive heart failure (CHF) in echocardiography Extensive air-space opacities in CXR  Small necrotizing granulomas with eosinophilic core surrounded by macrophages and epithelioid giant cells Histological confirmation Allergic rhinitis, Asthma, Urticarial rash
Hydralazine-associated ANCA-associated vasculitis[31] + +/- Anti-MPO antibody (P-ANCA), Anti-histone antibodies Anemia ↑Cr or BUN, Hypoalbuminemia Bilateral pulmonary infiltrates Aneurysms or occlusions of the visceral arteries Pauci-immune necrotizing and crescentic glomerulonephritis Histological confirmation Sinusitis, Hemoptysis
Immune complex small-vessel vasculitis Anti-glomerular basement membrane disease[32] + +/- + Anti-GBM antibodies Hypochromic microcytic anemia, Thrombocytopenia ↓C3 level Pulmonary hemorrhage Normal kidneys Alveolar infiltrates spreading from the hilum in CXR Cellular crescents in the glomeruli, Intra-alveolar hemorrhages Anti-GBM antibodies Hemoptysis, Hematuria
Cryoglobulinemic vasculitis[33] +/- +/- + +/- C4 component Leukocytosis, Anemia ↑ ANA, hypocomplementemia R/O underlying malignancy Stenosis or occlusions of the visceral arteries Bacterial endocarditis in echocardiography Interstitial involvement or pleural effusions in CXR HCV-associated proteins in vasculitic skin, Intraluminal cryoglobulin deposits  Histological confirmation Acrocyanosis, Retinal hemorrhage, Purpura
Hepatitis C virus-associated cryoglobulinemic vasculitis[34] +/- +/- + + + +/- HCV RNA, Cryoglobulins Leukocytosis, Anemia ↑ ↓Serum C4, Positive RF Increased hepatic echogenicity Hepatomegaly, Splenomegaly Increased hepatic echogenicity in MRI Vasculitic skin, Antigen infilteration in lesions HCV RNA, Histological confirmation Palpable purpura, Microscopic hematuria
IgA vasculitis (Henoch-Schönlein purpura)[35] + + IgA Normochromic anemia, Leukocytosis  ↑ Stool OB, ↓C3, ↓C4 Increased bowel wall thickness, hematomas, peritoneal fluid, and intussusception Dilated loops of bowel consistent in abdominal X-ray Leukocytoclastic vasculitis in postcapillary venules with IgA deposition History and physical examination Hematuria, Palpable purpura
Hypocomplementemic urticarial vasculitis (anti-C1q vasculitis)[36] +/- + C1q Mild anemia ↑ ANA, ↓C1q, ↓C3, ↓C4 Hepatomegaly, Splenomegaly Deposits of immunoglobulins, complement, or fibrin around blood vessels Urticaria,

Histological confirmation

Urticaria, Hematuria
Gastrointestinal disease Acute mesenteric ischemia[37] +/- I-FABP, Alpha-GST, Ischemia-modified albumin (IMA) Leukocytosis, ↑HCT  ↑Amylase Bowel wall thickening, Intestinal pneumatosis, Portomesenteric thrombosis Mesenteric venous thrombosis  Arterial stenosis or occlusion of the celiac or superior mesenteric arteries in duplex ultrasound Ileus with distended loops of bowel, Bowel wall thickening in abdominal X-ray Superficial mucosal hemorrhage, edema and necrosis History and physical examination Abdominal pain, Distension, Absent bowel sounds
Cardiovascular disease Infective Endocarditis[38] + + + + NT-proBNP Normochromic-normocytic anemia ↑ Hyperglobulinemia, Cryoglobulinemia Metastatic infections, such as splenic infarct, renal infarcts, or psoas abscess Vegetation, abscess, or new dehiscence of a prosthetic valvein echocardiography Vertebral osteomyelitis in MRI Vegetation or intracardiac abscess demonstrating active endocarditis Echocardiography (TTE) Janeway lesions, Osler nodes, Roth spots, Vertebral osteomyelitis
Leukocytoclastic Vasculitis[39] + + + IgM, IgA, IgG Leukocytosis, Anemia ↑ Hypocomplementemia Vascular stenosis and obstruction in visceral angiography Perivascular inflammatory infiltrate of neutrophils with leukocytoclasia (releasing nuclear debris) Histological confirmation Palpable purpura, Petechiae 
Pulmonary disease Langerhans Cell Histiocytosis[40] +/- + CD1a, CD207,BRAF-V600E Anemia ↑ Hypercalcemia Pulmonary cysts and nodules, Bone lytic lesions Hepatomegaly, Splenomegaly Cerebellum and pons hyperintensity in MRI Birbeck granules by electron microscopy Histological confirmation Brown to purplish papules, Eczematous rash
Non-Small Cell Lung Cancer[41] +/- + +/- EGFR, ROS1, EML4-ALK,  PD-L1 Leukocytosis, Anemia ↑ Hypercalcemia, Hyponatremia Pulmonary lesion or mass Pulmonary marginal lesions Staging and response to treatment in PET-CT Adenocarcinoma, Squamous cell carcinoma High resolution CT-scan Cough, Hemoptysis
Small Cell Lung Cancer[42] +/- + +/- p53, Thyroid transcription factor-1 (TTF1) Anemia ↑ Hyponatremia Large hilar mass with bulky mediastinal adenopathy Endobronchial ultrasound (EBUS) Standard staging Spindled cells with dark nuclei, scant cytoplasm, and fine, granular nuclear chromatin High resolution CT-scan Cough, Hemoptysis
Pulmonary Infarction[43] +/- + D-dimer Mild leukocytosis, Mild anemia Hypoxemia, Hypocarbia or Hypercarbia, Respiratory alkalosis Pulmonary embolism Low-density filling defect within the pulmonary artery Pericardial effusion in echocardiography Pulmonary infiltrates, atelectasis, and pleural effusions in CXR Infarct induced apoptosis Pulmonary artery angiography Cough, Hemoptysis
Renal disease Acute Poststreptococcal Glomerulonephritis[44] + + +/- Antistreptolysin-O (ASO) titers Leukocytosis ↑ Hypocomplementemia Normal to slightly enlarged kidneys Central venous congestion in a hilar pattern in CXR Hypercellularity of endothelial and mesangial cells, Infiltration of the glomerular tuft with polymorphonuclear cells Histological confirmation Hematuria
Hematologic disease Hemolytic-Uremic Syndrome[45] + + + + + C5b-9, ADAMTS13 Anemia, Thrombocytopenia, Reticulocytosis  ↑ ↑Lactate dehydrogenase (LDH), Hypercalcemia  Thalami, brainstem, or cerebellum abnormality Cerebral microangiopathy or hypertension Hypoechoic kidney  Abnormal hyperintensity in the brain cisterns in MRI Microthromboses include fibrin thrombi that may occlude the glomerular tuft Clinical findings coupled with laboratory abnormalities Hematuria, Proteinuria 
Chronic Lymphocytic Leukemia (CLL)[46] + + + + +/- +/- CD5, CD19, CD20, IgVH Absolute lymphocytosis, Smudge cells ↑ Flow cytometry Staging Large atypical cells, cleaved cells, and prolymphocytes  Chromosomal and genetic testing Easy bruising
Multiple Myeloma[47] + + + + + +/- +/- Ig light chain Anemia, Thrombocytopenia, Leukopenia ↑ Bone marrow aspiration and biopsy, ↑Cr Osseous involvement and lytic lesions Peripheral zone of increased vascularity in lesions Punched-out lesion in skull X-ray Clonal proliferation of plasma cells Protein electrophoresis plus conventional X-rays Constipation
Hypereosinophilic Syndrome[48] +/- +/- IgE, CD117 with CD2 Eosinophilia ↑Serum tryptase Lymphadenopathy and splenomegaly Intracardiac thrombi in echocardiography Reticulin stain for myelofibrosis and tryptase staining for mast cells Clinical findings coupled with laboratory abnormalities Splinter hemorrhages, Raynaud phenomenon
Non-Hodgkin Lymphoma[49] + + + + +/- +/- +/- +/- MYC, BCL2, BCL6, and TP53 Lymphocytosis, Anemia, Thrombocytopenia ↑ ↑Lactate dehydrogenase (LDH), Hypercalcemia  Enlarged lymph nodes, Hepatosplenomegaly, Filling defects in the liver and spleen Hepatosplenomegaly Mediastinal lymphadenopathy Small cleaved or noncleaved, intermediate, or large cell with a follicular or diffuse pattern Surgically excised tissue biopsy Easy bruising, Testicular mass, Skin lesion
Serum Sickness[50] + + +/- +/- +/- IL-1, IL-6, TNF Leukopenia  ↑ Polyclonal gammopathy, ↑Cr, Cryoglobulinemia Arteritic lesions are focal, necrotizing, and inflammatory involving all layers of the artery Clinical findings coupled with laboratory abnormalities Hematuria, Skin rash
Disseminated Intravascular Coagulation[51] +/- + +/- + + Fibrin degradation product (FDP) Thrombocytopenia, Schistocytes ↑ ↑D-dimer, aPTT and PT Intracranial hemorrhage Ischemia and necrosis due to fibrin deposition in small and medium-sized vessels Clinical findings coupled with laboratory abnormalities  Acral cyanosis, Hemorrhagic skin infarctions
Idiopathic Thrombocytopenic Purpura[52] + +/- + + FC gamma receptors (FCGR) IIb Anemia, Thrombocytopenia HIV, ANA R/O other causes R/O splenomegaly Increased number of normal morphologic megakaryocytes Clinical findings coupled with thrombocytopenia Easy bruising, Purpura
Systemic disease Sarcoidosis[53] + + + + +/-  IL-2 and IFN-γ Mild anemia ↑ ↑ACE, ↑1, 25-dihydroxyvitamin D Active alveolitis or fibrosis Hepatosplenomegaly Bilateral hilar adenopathy Noncaseating granulomas (NCGs) Histological confirmation Heart block, Ocular lesion
Legionella Infection[54] + + + + +/- Inflammatory cytokines Leukocytosis with left shift, Thrombocytosis ↑ ↑D-dimer, FDP, Hyponatremia Pleural effusion Nonspecific and indistinguishable CXR Intra-alveolar inflammation, Microabscesses in the parenchyma Sputum culture Cough, Diarrhea
Systemic lupus erythematosus[55] + + + + + + Anti dsDNA, ANA  Leukopenia, Lymphopenia, Anemia, Thrombocytopenia ↑ ↑Cr or BUN,

↑ALT or AST, Proteinuria

Interstitial lung disease, Pneumonitis, Pulmonary emboli, Alveolar hemorrhage Aneurysms Pericardial effusion, pulmonary hypertension, or verrucous Libman-Sacks endocarditis in echocardiography Central nervous system (CNS) lupus white-matter changes in MRI  Staging lupus nephritis Anti-dsDNA antibody test Skin rashes or photosensitivity
Rheumatoid arthritis[56] + + + + RF, Anti-CCP antibody Anemia ↑ ↑Cr or BUN,

↑ALT or AST, ANA

Microfractures Aneurysms Effusions in joints Basilar invagination with cranial migration of an eroded odontoid peg in MRI Influx of inflammatory cells into the synovial membrane, with angiogenesis, proliferation of chronic inflammatory cells Clinical findings coupled anti-CCP antibody Rheumatoid nodules
Relapsing polychondritis[57] +/- +/- + + Leukocytosis, Anemia Cryoglobulins, ANA, C-ANCA Calcification of cartilaginous structures Aortic root dilatation Aortic root dilatation and degree of aortic regurgitation in echocardiography Tracheal stenosis in CXR Chondrolysis, Chondritis, Perichondritis Clinical findings coupled with imaging Ear pain and redness, Polyarthritis
Diseases Headache Fever Weight loss Arthralgia Claudication Bruit HTN Focal neurological disorder Biomarker CBC ESR Other CT scan Angiography Ultrasound/ Echocardiography Other Histopathology Gold standard Additional findings
Variable-vessel vasculitis Behçet’s syndrome[58] + +/- CXCL1  Mild anemia, Neutrophilia ↑ Factor V Leiden Focal CNS lesions Aneurysm formation and thrombosis areas Valve vegetations and ventricular thrombi in echocardiography Meningoencephalitis  in MRI Lymphocytic and plasma cell invasion in the prickle cell layer of the epidermis Clinical criteria Genital ulcerations, Oral ulceration
Cogan’s syndrome[59] +/- +/- +  Anti-Hsp70 antibodies Anemia, Thrombocytosis ↑ RF, ANA Thickening and enhancement of both posterior sclera  Stenosis, thrombosis or more lesions in aortic root Aortic insufficiency in echocardiography Early interstitial keratitis by slit lamp Muscle necrosis and atrophy resembling myositis Red eye, Hearing loss, Vertigo
Gastrointestinal disease Inflammatory Bowel Disease[60] +/- + + + + Anti-Saccharomyces cerevisiae antibody (ASCA), P-ANCA Leukocytosis, Anemia ↑  Iron or vitamin deficiency, Stool OB Mesenteric fat stranding, bowel wall enhancement, increased vascularity (comb sign) Fistulas, Abscesses, Stenosis Grossly denuded mucosa with active bleeding in colonoscopy Crypt abscesses and mucosal ulceration, Granulomas  Endoscopy  GI bleeding
Whipple’s disease[61] + +/- + + + + + + CCR6, Gut-homing marker integrin ÎČ7-chain, T whippelii DNA Mild anemia, Neutrophilia ↑ 72-hour fecal fat determination Nonspecific malabsorption Hepatosplenomegaly Periodic acid-Schiff–positive macrophages infiltration in lamina propria of the small bowel Broad-spectrum PCR amplifications Cachexia,

Glossitis

Sjögren’s syndrome[62] +/- + Anti-Ro and Anti-La, Anti-alpha-fodrin antibody Anemia,

Leukopenia,

Eosinophilia

↑ Hypergammaglobulinemia, Low bicarbonate level, Hypokalemia  Salt and pepper or honeycomb appearance in parotid glands Multicystic or reticular pattern in atrophic salivary gland R/O obstructions or strictures with Sialography  Focal aggregates of lymphocytes Schirmer test Keratoconjunctivitis, Gingival inflammation
Single-organ vasculitis Primary central nervous system vasculitis[63] + + + + + + von Willebrand factor antigen (vWF) Normal CSF pleocytosis, predominantly lymphocytes Cerebral infarcts or hemorrhages with mass effect, or hydrocephalus Aneurysm in circle of Willis Progression of the disease or response to therapy in MRI Chronic granulomatous inflammation and giant cells Histological confirmation Skin rash, Purpura
Infectious disease Aspergillosis[64] + + + + Aspergillus nucleic acid in blood, Galactomannan Eosinophilia ↑ ↑Serum IgE Aspergilloma mass within a cavity Mass effect stenosis Aspergilloma mass within the brain in MRI Septate hyphae, branching at acute angles, and tissue necrosis with granulomata and blood vessel invasion Histological confirmation Hemoptysis, Aspergilloma
Histoplasmosis[65] + + + + + + Mild anemia ↑ ↑ALP, ↑LDH Cerebral histoplasmosis  Valvular involvement in echocardiography PFT Presence of yeast forms in tissue through hematoxylin and eosin staining Sputum cultures Pneumonia, Mediastinitis
Herpes Simplex Encephalitis[66] + + + HSV DNA Mild lymphocytosis ↑ CSF pleocytosis Low-density lesions in the temporal and/or frontal lobe Hemorrhagic lesion in white matter Multinuclear giant cells PCR or brain biopsy Seizures,

Vomiting

Systemic disease Eclampsia[67] + + + + + VEGF, PlGF, Soluble FLT-1 Anemia, Thrombocytopenia, Schistocytes ↑Bilirubin, ↓Haptoglobin, ↑LDH, ↑Cr Cortical hypodense areas in the occipital lobes, Diffuse cerebral edema Poor fetal growth, Oligohydramnios, Abnormal umbilical artery  Increased signal at the gray-white matter junction in MRI 24-hour urine study  Seizure, Edema
Fibromuscular dysplasia[6] + +/- + + + + +/- Transforming growth factor ÎČ (TGF-ÎČ) Normal ↑ ↑ Cr or BUN Alternating stenosis and dilatations in CT angiography Stenosis in the renal arteries Luminal narrowing alternating with dilatation (Beads sign) Focal concentric, long-segment tubular stenosis or outpouching in MRA Fibrodysplastic changes, Collagen deposition Digital subtraction angiography (DSA)  Spontaneous coronary artery dissection (SCAD)

References

  1. ↑ Vaideeswar P, Deshpande JR (2013). “Pathology of Takayasu arteritis: A brief review”. Ann Pediatr Cardiol. 6 (1): 52–8. doi:10.4103/0974-2069.107235. PMC 3634248. PMID 23626437.
  2. ↑ Calvo-Romero JM (2003). “Giant cell arteritis”. Postgrad Med J. 79 (935): 511–5. PMC 1742823. PMID 13679546.
  3. ↑ Stafa A, Leonardi M (2008). “Role of neuroradiology in evaluating cerebral aneurysms”. Interv Neuroradiol. 14 Suppl 1: 23–37. doi:10.1177/15910199080140S106. PMC 3328052. PMID 20557771.
  4. ↑ Cassiman C, Casteels I, Stalmans P, Legius E, Jacob J (2017). “Optical Coherence Tomography Angiography of Retinal Microvascular Changes Overlying Choroidal Nodules in Neurofibromatosis Type 1”. Case Rep Ophthalmol. 8 (1): 214–220. doi:10.1159/000469702. PMC 5422752. PMID 28512424.
  5. ↑ Evans, D G. R (2000). “Neurofibromatosis type 2”. Journal of Medical Genetics. 37 (12): 897–904. doi:10.1136/jmg.37.12.897. ISSN 1468-6244.
  6. ↑ 6.0 6.1 Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X (2007). “Fibromuscular dysplasia”. Orphanet J Rare Dis. 2: 28. doi:10.1186/1750-1172-2-28. PMC 1899482. PMID 17555581.
  7. ↑ Gazit Y, Jacob G, Grahame R (2016). “Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder”. Rambam Maimonides Med J. 7 (4). doi:10.5041/RMMJ.10261. PMC 5101008. PMID 27824552.
  8. ↑ Michet CJ, Matteson EL (2008). “Polymyalgia rheumatica”. BMJ. 336 (7647): 765–9. doi:10.1136/bmj.39514.653588.80. PMC 2287267. PMID 18390527.
  9. ↑ Baker KR, Rice L (2012). “The amyloidoses: clinical features, diagnosis and treatment”. Methodist Debakey Cardiovasc J. 8 (3): 3–7. PMC 3487569. PMID 23227278.
  10. ↑ Howard T, Ahmad K, Swanson JA, Misra S (2014). “Polyarteritis nodosa”. Tech Vasc Interv Radiol. 17 (4): 247–51. doi:10.1053/j.tvir.2014.11.005. PMC 4363102. PMID 25770638.
  11. ↑ Sharma A, Sharma K (September 2013). “Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis”. J Clin Exp Hepatol. 3 (3): 204–12. doi:10.1016/j.jceh.2013.06.001. PMC 4216827. PMID 25755502.
  12. ↑ Takahashi K, Oharaseki T, Yokouchi Y (2011). “Pathogenesis of Kawasaki disease”. Clin Exp Immunol. 164 Suppl 1: 20–2. doi:10.1111/j.1365-2249.2011.04361.x. PMC 3095860. PMID 21447126.
  13. ↑ Heegaard ED, Brown KE (2002). “Human parvovirus B19”. Clin Microbiol Rev. 15 (3): 485–505. PMC 118081. PMID 12097253.
  14. ↑ Basetti S, Hodgson J, Rawson TM, Majeed A (2017). “Scarlet fever: a guide for general practitioners”. London J Prim Care (Abingdon). 9 (5): 77–79. doi:10.1080/17571472.2017.1365677. PMC 5649319. PMID 29081840.
  15. ↑ Vostral SL (2011). “Rely and Toxic Shock Syndrome: a technological health crisis”. Yale J Biol Med. 84 (4): 447–59. PMC 3238331. PMID 22180682.
  16. ↑ Balfour HH, Dunmire SK, Hogquist KA (2015). “Infectious mononucleosis”. Clin Transl Immunology. 4 (2): e33. doi:10.1038/cti.2015.1. PMC 4346501. PMID 25774295.
  17. ↑ Levett PN (April 2001). “Leptospirosis”. Clin. Microbiol. Rev. 14 (2): 296–326. doi:10.1128/CMR.14.2.296-326.2001. PMC 88975. PMID 11292640.
  18. ↑ Biesiada G, Czepiel J, Leƛniak MR, Garlicki A, Mach T (2012). “Lyme disease: review”. Arch Med Sci. 8 (6): 978–82. doi:10.5114/aoms.2012.30948. PMC 3542482. PMID 23319969.
  19. ↑ White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM (2012). “Measles, mumps, and rubella”. Clin Obstet Gynecol. 55 (2): 550–9. doi:10.1097/GRF.0b013e31824df256. PMC 3334858. PMID 22510638.
  20. ↑ Walker DH (1989). “Rocky Mountain spotted fever: a disease in need of microbiological concern”. Clin Microbiol Rev. 2 (3): 227–40. PMC 358117. PMID 2504480.
  21. ↑ Mishra AK, Yadav P, Mishra A (2016). “A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates”. Open Microbiol J. 10: 150–9. doi:10.2174/1874285801610010150. PMC 5012080. PMID 27651848.
  22. ↑ Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E; et al. (2016). “Toxic epidermal necrolysis”. F1000Res. 5. doi:10.12688/f1000research.7574.1. PMC 4879934. PMID 27239294.
  23. ↑ MacGowan SW, Sidhu P, Aherne T, Luke D, Wood AE, Neligan MC, McGovern E (June 1993). “Atrial myxoma: national incidence, diagnosis and surgical management”. Ir J Med Sci. 162 (6): 223–6. PMID 8407260.
  24. ↑ Avci G, Akoz T, Gul AE (2009). “Cutaneous cholesterol embolization”. J Dermatol Case Rep. 3 (2): 27–9. doi:10.3315/jdcr.2009.1031. PMC 3157794. PMID 21886725.
  25. ↑ Chao, Christine (2009). “Segmental Arterial Mediolysis”. Seminars in Interventional Radiology. 26 (03): 224–232. doi:10.1055/s-0029-1225666. ISSN 0739-9529.
  26. ↑ Chaturvedi S, McCrae KR (2015). “The antiphospholipid syndrome: still an enigma”. Hematology Am Soc Hematol Educ Program. 2015: 53–60. doi:10.1182/asheducation-2015.1.53. PMC 4877624. PMID 26637701.
  27. ↑ Espinosa M, Gottlieb BS (July 2012). “Juvenile idiopathic arthritis”. Pediatr Rev. 33 (7): 303–13. doi:10.1542/pir.33-7-303. PMID 22753788.
  28. ↑ Chung SA, Seo P (2010). “Microscopic polyangiitis”. Rheum Dis Clin North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.
  29. ↑ Kubaisi B, Abu Samra K, Foster CS (2016). “Granulomatosis with polyangiitis (Wegener’s disease): An updated review of ocular disease manifestations”. Intractable Rare Dis Res. 5 (2): 61–9. doi:10.5582/irdr.2016.01014. PMC 4869584. PMID 27195187.
  30. ↑ Keogh KA, Specks U (April 2006). “Churg-Strauss syndrome”. Semin Respir Crit Care Med. 27 (2): 148–57. doi:10.1055/s-2006-939518. PMID 16612766.
  31. ↑ Keasberry J, Frazier J, Isbel NM, Van Eps CL, Oliver K, Mudge DW (2013). “Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report”. J Med Case Rep. 7: 20. doi:10.1186/1752-1947-7-20. PMC 3565908. PMID 23316942.
  32. ↑ McAdoo SP, Pusey CD (July 2017). “Anti-Glomerular Basement Membrane Disease”. Clin J Am Soc Nephrol. 12 (7): 1162–1172. doi:10.2215/CJN.01380217. PMID 28515156.
  33. ↑ Ferri C, Mascia MT (January 2006). “Cryoglobulinemic vasculitis”. Curr Opin Rheumatol. 18 (1): 54–63. PMID 16344620.
  34. ↑ Guo QY, Wu M, Wang YW, Sun GD (2017). “Hepatitis C virus-associated cryoglobulinemia with membrano-proliferative glomerulonephritis treated with prednisolone and interferon: A case report”. Exp Ther Med. 14 (2): 1395–1398. doi:10.3892/etm.2017.4671. PMC 5525644. PMID 28810602.
  35. ↑ Farhadian JA, Castilla C, Shvartsbeyn M, Meehan SA, Neimann A, Pomeranz MK (December 2015). “IgA vasculitis (Henoch-Schönlein purpura)”. Dermatol. Online J. 21 (12). PMID 26990342.
  36. ↑ Buck A, Christensen J, McCarty M (2012). “Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review”. J Clin Aesthet Dermatol. 5 (1): 36–46. PMC 3277093. PMID 22328958.
  37. ↑ Sise MJ (February 2014). “Acute mesenteric ischemia”. Surg. Clin. North Am. 94 (1): 165–81. doi:10.1016/j.suc.2013.10.012. PMID 24267504.
  38. ↑ McDonald JR (2009). “Acute infective endocarditis”. Infect Dis Clin North Am. 23 (3): 643–64. doi:10.1016/j.idc.2009.04.013. PMC 2726828. PMID 19665088.
  39. ↑ Einhorn J, Levis JT (2015). “Dermatologic Diagnosis: Leukocytoclastic Vasculitis”. Perm J. 19 (3): 77–8. doi:10.7812/TPP/15-001. PMC 4500485. PMID 26176572.
  40. ↑ Margo CE, Goldman DR (2008). “Langerhans cell histiocytosis”. Surv Ophthalmol. 53 (4): 332–58. doi:10.1016/j.survophthal.2008.04.007. PMID 18572052.
  41. ↑ Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008). “Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship”. Mayo Clin Proc. 83 (5): 584–94. doi:10.4065/83.5.584. PMC 2718421. PMID 18452692.
  42. ↑ Jackman DM, Johnson BE (2005). “Small-cell lung cancer”. Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
  43. ↑ Parambil JG, Savci CD, Tazelaar HD, Ryu JH (April 2005). “Causes and presenting features of pulmonary infarctions in 43 cases identified by surgical lung biopsy”. Chest. 127 (4): 1178–83. doi:10.1378/chest.127.4.1178. PMID 15821192.
  44. ↑ VanDeVoorde RG (January 2015). “Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis”. Pediatr Rev. 36 (1): 3–12, quiz 13. doi:10.1542/pir.36-1-3. PMID 25554106.
  45. ↑ Corrigan JJ, Boineau FG (November 2001). “Hemolytic-uremic syndrome”. Pediatr Rev. 22 (11): 365–9. PMID 11691946.
  46. ↑ Byrd JC, Stilgenbauer S, Flinn IW (2004). “Chronic lymphocytic leukemia”. Hematology Am Soc Hematol Educ Program: 163–83. doi:10.1182/asheducation-2004.1.163. PMID 15561682.
  47. ↑ Michels TC, Petersen KE (March 2017). “Multiple Myeloma: Diagnosis and Treatment”. Am Fam Physician. 95 (6): 373–383. PMID 28318212.
  48. ↑ Klion A (2009). “Hypereosinophilic syndrome: current approach to diagnosis and treatment”. Annu. Rev. Med. 60: 293–306. doi:10.1146/annurev.med.60.062107.090340. PMID 19630574.
  49. ↑ Shankland KR, Armitage JO, Hancock BW (September 2012). “Non-Hodgkin lymphoma”. Lancet. 380 (9844): 848–57. doi:10.1016/S0140-6736(12)60605-9. PMID 22835603.
  50. ↑ Lin RY (January 1986). “Serum sickness syndrome”. Am Fam Physician. 33 (1): 157–62. PMID 2867672.
  51. ↑ Venugopal A (2014). “Disseminated intravascular coagulation”. Indian J Anaesth. 58 (5): 603–8. doi:10.4103/0019-5049.144666. PMC 4260307. PMID 25535423.
  52. ↑ Nomura S (2016). “Advances in Diagnosis and Treatments for Immune Thrombocytopenia”. Clin Med Insights Blood Disord. 9: 15–22. doi:10.4137/CMBD.S39643. PMC 4948655. PMID 27441004.
  53. ↑ Chiarchiaro J, Chen BB, Gibson KF (2016). “New molecular targets for the treatment of sarcoidosis”. Curr Opin Pulm Med. 22 (5): 515–21. doi:10.1097/MCP.0000000000000304. PMC 5152532. PMID 27454074.
  54. ↑ Murdoch DR (January 2003). “Diagnosis of Legionella infection”. Clin. Infect. Dis. 36 (1): 64–9. doi:10.1086/345529. PMID 12491204.
  55. ↑ Tsokos, George C. (2011). “Systemic Lupus Erythematosus”. New England Journal of Medicine. 365 (22): 2110–2121. doi:10.1056/NEJMra1100359. ISSN 0028-4793.
  56. ↑ Scott JT (1991). “The gold standard in rheumatoid arthritis”. J R Soc Med. 84 (9): 513–4. PMC 1293405. PMID 1682491.
  57. ↑ Emmungil H, Aydın SZ (2015). “Relapsing polychondritis”. Eur J Rheumatol. 2 (4): 155–159. doi:10.5152/eurjrheum.2015.0036. PMC 5047229. PMID 27708954.
  58. ↑ Yazici H, Fresko I, Yurdakul S (March 2007). “Behçet’s syndrome: disease manifestations, management, and advances in treatment”. Nat Clin Pract Rheumatol. 3 (3): 148–55. doi:10.1038/ncprheum0436. PMID 17334337.
  59. ↑ Iliescu DA, Timaru CM, Batras M, De Simone A, Stefan C (2015). “COGAN’S SYNDROME”. Rom J Ophthalmol. 59 (1): 6–13. PMC 5729811. PMID 27373108.
  60. ↑ Wehkamp J, Götz M, Herrlinger K, Steurer W, Stange EF (2016). “Inflammatory Bowel Disease”. Dtsch Arztebl Int. 113 (5): 72–82. doi:10.3238/arztebl.2016.0072. PMC 4782273. PMID 26900160.
  61. ↑ Dutly F, Altwegg M (2001). “Whipple’s disease and “Tropheryma whippelii. Clin Microbiol Rev. 14 (3): 561–83. doi:10.1128/CMR.14.3.561-583.2001. PMC 88990. PMID 11432814.
  62. ↑ Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T (2017). “The Diagnosis and Treatment of Sjögren’s Syndrome”. Dtsch Arztebl Int. 114 (20): 354–361. doi:10.3238/arztebl.2017.0354. PMC 5471601. PMID 28610655.
  63. ↑ Benseler SM, Silverman E, Aviv RI, Schneider R, Armstrong D, Tyrrell PN, deVeber G (April 2006). “Primary central nervous system vasculitis in children”. Arthritis Rheum. 54 (4): 1291–7. doi:10.1002/art.21766. PMID 16575852.
  64. ↑ LatgĂ© JP (1999). “Aspergillus fumigatus and aspergillosis”. Clin Microbiol Rev. 12 (2): 310–50. PMC 88920. PMID 10194462.
  65. ↑ GuimarĂŁes AJ, Nosanchuk JD, ZancopĂ©-Oliveira RM (2006). “DIAGNOSIS OF HISTOPLASMOSIS”. Braz J Microbiol. 37 (1): 1–13. doi:10.1590/S1517-83822006000100001. PMC 2863343. PMID 20445761.
  66. ↑ Sköldenberg B (1996). “Herpes simplex encephalitis”. Scand J Infect Dis Suppl. 100: 8–13. PMID 9163027.
  67. ↑ Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM (2011). “Pre-eclampsia: pathophysiology, diagnosis, and management”. Vasc Health Risk Manag. 7: 467–74. doi:10.2147/VHRM.S20181. PMC 3148420. PMID 21822394.


Template:WH Template:WS

Epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The incidence of HSP is approximately 6-20 cases per 100,000 individuals. The prevalence of HSP is more in children of 4-6 years age group. HSP usually affects Caucasians than any other ethnic groups. Males are more commonly affected by HSP than females. The Male to female ratio is approximately 1.5-2:1.

Epidemiology and demgraphics

Epidemiology and demgraphics of HSP:[1][2]

Incidence

  • The incidence of HSP is approximately 6-20 cases per 100,000 individuals.

Age

  • The prevalence of HSP is more in children of 4-6 years age group.

Race

  • HSP usually affects Caucasians than any other ethnic groups.

Gender

  • Males are more commonly affected by HSP than females. The Male to female ratio is approximately 1.5-2:1.

References

  1. ↑ Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, Lee SK, Park YB (February 2014). “Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura”. J. Korean Med. Sci. 29 (2): 198–203. doi:10.3346/jkms.2014.29.2.198. PMC 3923997. PMID 24550645.
  2. ↑ Schmoldt A, Benthe HF, Haberland G, Sinelnikova EM, Dvoretskova TV, Kagan ZS, Horty JF, Geering K, Becker M, Beglinger R, Stauffer UG (September 1975). “Digitoxin metabolism by rat liver microsomes”. Biochem. Pharmacol. 24 (17): 1639–41. PMID 10.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Henoch-Schönlein purpura (HSP) is associated with following risk factors it’s most common in children of 2 to 6 years, involves young boys more than girls, Asian and white race, spring, fall and winter months, Group A streptococci, Mycoplasma, Epstein-Barr virus infections, and environmental exposure of allergens, organophosphates, cold temperature.

Risk Factors

The risk factors of the Henoch-Schönlein purpura are as follows:[1][2][3][4][5]

References

  1. ↑ Park SJ, Suh JS, Lee JH, Lee JW, Kim SH, Han KH, Shin JI (December 2013). “Advances in our understanding of the pathogenesis of Henoch-Schönlein purpura and the implications for improving its diagnosis”. Expert Rev Clin Immunol. 9 (12): 1223–38. doi:10.1586/1744666X.2013.850028. PMID 24215411.
  2. ↑ Saulsbury FT (January 2001). “Henoch-Schönlein purpura”. Curr Opin Rheumatol. 13 (1): 35–40. PMID 11148713.
  3. ↑ Bucher B, Fiore E, Bernasconi M, Blumberg D, Garzoni L, Rizzi M, Bianchetti MG (May 2008). “[Childhood Henoch-Schönlein syndrome–common and uncommon features, complications, Finkelstein-Seidlmayer variant and management]”. Ther Umsch (in German). 65 (5): 269–77. doi:10.1024/0040-5930.65.5.269. PMID 18622931.
  4. ↑ Nunnelee JD (March 2000). “Henoch-Schönlein purpura: a review of the literature”. Clin Excell Nurse Pract. 4 (2): 72–5. PMID 11075047.
  5. ↑ Patrignelli R, Sheikh SH, Shaw-Stiffel TA (May 1995). “Henoch-Schönlein purpura. A multisystem disease also seen in adults”. Postgrad Med. 97 (5): 123–4, 127, 131–4. PMID 7753737.


Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Henoch-Schönlein purpura is a self-limiting illness in the majority of patients but can rarely lead to complications such as proteinuria, End Stage Renal Disease, myocardial infarction, pulmonary hemorrhage, pleural effusion, intussusception, orchitis, GI bleeding, bowel infarction, seizures, neuropathies. The prognosis is usually good but rarely its worse in adults with renal involvement.

Natural History

  • The natural history of HSP is as follows:[1][2][3][4][5][6][7]
  • Henoch-Schönlein purpura is a self-limiting illness in the majority of patients.
  • The abdominal and joint pain may be debilitating, and steroids have been used with some success in relieving the abdominal pain.
  • The vasculitis of the gastrointestinal tract causes significant blood loss and occasionally leading to bowel ischemia, which may necessitate bowel resection.
  • There is no clear evidence that remedy alters the progression of the HSP, however, the significant long-term morbidity related to the renal disease that has led to trials of steroids and other immunosuppressive drugs.

Complications

The complications of the HSP are as follows:[1][2][3][4][5][6][7]

  • Renal involvement- Proteinuria, End Stage Renal Disease in 1% of patients.

Prognosis

  • The prognosis of the HSP:[8][2][9][10][11][12]
  • Henoch-Schönlein purpura is an acute self-limited illness, can seldom cause complications.
  • Initial attacks of HSP can last for several months. One in every four patients will have one or more recurrences.
  • HSP is more benign, short course and less recurrent in children less than three years.
  • CKD can progress more than 10 years after the initial HSP attack.
  • The long-term prognosis of HSP depends on the extent of the kidney involvement.
  • Renal involvement of more common and the prognosis is worst in adults with HSP than the children.

References

  1. ↑ 1.0 1.1 Scheller F, JĂ€nchen M, Lampe J, PrĂŒmke HJ, Blanck J, Palecek E, Chow YW, Pietranico R, Mukerji A, Reynolds CH (November 1975). “Studies on electron transfer between mercury electrode and hemoprotein”. Biochim. Biophys. Acta. 412 (1): 157–67. PMID 79.
  2. ↑ 2.0 2.1 2.2 Trnka P (December 2013). “Henoch-Schönlein purpura in children”. J Paediatr Child Health. 49 (12): 995–1003. doi:10.1111/jpc.12403. PMID 24134307.
  3. ↑ 3.0 3.1 Kanaan N, Mourad G, Thervet E, Peeters P, Hourmant M, Vanrenterghem Y, De Meyer M, Mourad M, MarĂ©chal C, Goffin E, Pirson Y (July 2011). “Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysis”. Clin J Am Soc Nephrol. 6 (7): 1768–72. doi:10.2215/CJN.00520111. PMID 21734091.
  4. ↑ 4.0 4.1 Samuel JP, Bell CS, Molony DA, Braun MC (August 2011). “Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura”. Clin J Am Soc Nephrol. 6 (8): 2034–40. doi:10.2215/CJN.01410211. PMC 3359547. PMID 21700827.
  5. ↑ 5.0 5.1 Poterucha TJ, Wetter DA, Grande JP, Gibson LE, Camilleri MJ, Lohse CM (July 2014). “A retrospective comparison of skin and renal direct immunofluorescence findings in patients with glomerulonephritis in adult Henoch-Schönlein purpura”. J. Cutan. Pathol. 41 (7): 582–7. PMID 25097917.
  6. ↑ 6.0 6.1 D’Souza S, Hageman JR, Patel P, Littlejohn E (March 2014). “Henoch-Schöenlein purpura and diabetes mellitus in a 9-year-old African-American male”. Pediatr Ann. 43 (3): e61–4. doi:10.3928/00904481-20140221-09. PMID 24605861.
  7. ↑ 7.0 7.1 Pohl M (February 2015). “Henoch-Schönlein purpura nephritis”. Pediatr. Nephrol. 30 (2): 245–52. doi:10.1007/s00467-014-2815-6. PMID 24733586.
  8. ↑ Pillebout E, Verine J (June 2014). “[Henoch-Schönlein purpura in the adult]”. Rev Med Interne (in French). 35 (6): 372–81. doi:10.1016/j.revmed.2013.12.004. PMID 24657040.
  9. ↑ Davin JC, Coppo R (October 2014). “Henoch-Schönlein purpura nephritis in children”. Nat Rev Nephrol. 10 (10): 563–73. doi:10.1038/nrneph.2014.126. PMID 25072122.
  10. ↑ Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, Hosoya M (2013). “Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment”. Fukushima J Med Sci. 59 (1): 15–26. PMID 23842510.
  11. ↑ Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, Lee SK, Park YB (February 2014). “Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura”. J. Korean Med. Sci. 29 (2): 198–203. doi:10.3346/jkms.2014.29.2.198. PMC 3923997. PMID 24550645.
  12. ↑ Davin JC (March 2011). “Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy”. Clin J Am Soc Nephrol. 6 (3): 679–89. doi:10.2215/CJN.06710810. PMID 21393485.

Template:WH Template:WS

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy

Case Studies

Case Studies

Case #1

Template:Hematology

de:Purpura Schönlein-Henoch nl:Purpura van Henoch-Schönlein sv:Henoch-Schönleins purpura


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut fĂŒr Telematik in der Medizin GmbH